Facebook Linkedin Twitter
Inside Precision Medicine Tumor Biomarkers Culled from Errant Transcripts

Computational molecular biology

Source: Sciepro/Getty Images
Molecular Dx

Tumor Biomarkers Culled from Errant Transcripts

Patricia Fitzpatrick Dimond, Ph.D.
0
Qiagen has rolled out an improved version of its Qiagen Clinical Insight (QCI) software that incorporates the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer. [Source: © Mopic/Fotolia.com]
Molecular Dx

Qiagen Integrates AMP/ASCO/CAP Variant Guidelines Into QCI-Interpret Solution

0
Hand inserts a molecule into DNA.
Molecular Dx

Scientists Develop Chip-Based Platform to Scan DNA for Off-Target CRISPR Effects

0
Qiagen’s NGS portfolio includes the GeneReader NGS System
Molecular Dx

Qiagen, BMS to Develop Gene Expression Profiles for I-O Therapies Using NGS

0
Targeted RNA Expression Profiling Assay
News & Features

Targeted RNA Expression Profiling Assay

0
Businessmen shaking hands in office
Informatics

MPI to License Drug Response Prediction Technology to Oncology Venture Sweden

0
Seamless DNA background
News & Features

Sarah Cannon Research Institute to Leverage Foundation Medicine’s Genomic Profiling Expertise

0
Cancer cells - 3d rendered illustration
News & Features

Sanford Health Enrolling Patients for Genomic Profiling Research

0
Social Business
News & Features

Mount Sinai Crowdsources Analysis and Annotation of Gene Expression Profiles

0
Kidney cancer
News & Features

Gene Profiling May Help Identify Renal Cancer Patients Unlikely to Benefit from Immunotherapy

0
1234Page 3 of 4

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine